LPCN
Price
$3.19
Change
-$0.19 (-5.62%)
Updated
Nov 19, 04:49 PM (EDT)
Capitalization
17.93M
Intraday BUY SELL Signals
SPRY
Price
$7.10
Change
+$0.01 (+0.14%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
700.84M
120 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LPCN vs SPRY

Header iconLPCN vs SPRY Comparison
Open Charts LPCN vs SPRYBanner chart's image
Lipocine
Price$3.19
Change-$0.19 (-5.62%)
Volume$200
Capitalization17.93M
ARS Pharmaceuticals
Price$7.10
Change+$0.01 (+0.14%)
Volume$54.51K
Capitalization700.84M
LPCN vs SPRY Comparison Chart in %
LPCN
Daily Signal:
Gain/Loss:
SPRY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LPCN vs. SPRY commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LPCN is a Hold and SPRY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (LPCN: $3.23 vs. SPRY: $7.09)
Brand notoriety: LPCN and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LPCN: 978% vs. SPRY: 100%
Market capitalization -- LPCN: $17.82M vs. SPRY: $700.84M
LPCN [@Biotechnology] is valued at $17.82M. SPRY’s [@Biotechnology] market capitalization is $700.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LPCN’s FA Score shows that 0 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • LPCN’s FA Score: 0 green, 5 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, LPCN is a better buy in the long-term than SPRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LPCN’s TA Score shows that 4 TA indicator(s) are bullish while SPRY’s TA Score has 4 bullish TA indicator(s).

  • LPCN’s TA Score: 4 bullish, 6 bearish.
  • SPRY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SPRY is a better buy in the short-term than LPCN.

Price Growth

LPCN (@Biotechnology) experienced а +11.76% price change this week, while SPRY (@Biotechnology) price change was -19.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

SPRY is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRY($701M) has a higher market cap than LPCN($17.9M). SPRY (-32.796) and LPCN (-33.811) have similar YTD gains . LPCN has higher annual earnings (EBITDA): -5.52M vs. SPRY (-59.34M). SPRY has more cash in the bank: 240M vs. LPCN (17.9M). LPCN has less debt than SPRY: LPCN (1.48M) vs SPRY (1.66M). SPRY has higher revenues than LPCN: SPRY (112M) vs LPCN (4.21M).
LPCNSPRYLPCN / SPRY
Capitalization17.9M701M3%
EBITDA-5.52M-59.34M9%
Gain YTD-33.811-32.796103%
P/E RatioN/A151.25-
Revenue4.21M112M4%
Total Cash17.9M240M7%
Total Debt1.48M1.66M89%
FUNDAMENTALS RATINGS
LPCN: Fundamental Ratings
LPCN
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
18

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LPCNSPRY
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
Bearish Trend 16 days ago
88%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
LPCN
Daily Signal:
Gain/Loss:
SPRY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AU80.102.34
+3.01%
AngloGold Ashanti plc
TRX0.630.01
+1.08%
TRX Gold Corp
SLGN37.920.36
+0.96%
Silgan Holdings
GIGM1.56N/A
-0.31%
GigaMedia Limited
AVBP20.18-0.51
-2.46%
ArriVent BioPharma

LPCN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LPCN has been loosely correlated with SPRY. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if LPCN jumps, then SPRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LPCN
1D Price
Change %
LPCN100%
+7.67%
SPRY - LPCN
63%
Loosely correlated
-3.14%
HYFT - LPCN
43%
Loosely correlated
+2.33%
ZNTL - LPCN
36%
Loosely correlated
+3.41%
JANX - LPCN
31%
Poorly correlated
+1.04%
TARA - LPCN
30%
Poorly correlated
+21.18%
More

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with LPCN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then LPCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
-3.14%
LPCN - SPRY
63%
Loosely correlated
+7.67%
KROS - SPRY
34%
Loosely correlated
+0.98%
DAWN - SPRY
32%
Poorly correlated
-3.17%
ANAB - SPRY
31%
Poorly correlated
+6.44%
REPL - SPRY
31%
Poorly correlated
-0.34%
More